Literature DB >> 8336889

Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery.

V P Costa1, R P Wilson, M R Moster, C M Schmidt, S Gandham.   

Abstract

Intraoperative mitomycin C has been shown to be highly effective in increasing the success rate of glaucoma filtration surgery. Between October 1991 and June 1992, 169 eyes of 156 patients underwent filtration procedures with intraoperative mitomycin C. In the postoperative period, five eyes (2.9%) developed hypotony maculopathy, characterized by disc edema, vascular tortuosity, and chorioretinal folds in the macular area. Cryotherapy was applied to three eyes, and was effective in reversing the hypotony in two of them. However, the visual prognosis was poor: after a mean follow up of 5.3 months (range, 3.5 to 8 months), visual acuity returned to preoperative levels in one case. Hypotony maculopathy may develop after glaucoma filtration surgery with intraoperative mitomycin C. We suggest restricting the indication of its adjunctive use to eyes with poor surgical prognosis or those in which a very low intraocular pressure is desired. The use of extra sutures (which can be sectioned by laser) or releasable sutures to prevent excessive filtration in the postoperative period also is advisable.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8336889

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  31 in total

1.  Decorin and suramin inhibit ocular fibroblast collagen production.

Authors:  H Mietz; P Chévez-Barrios; M W Lieberman; M Wendt; R Gross; S F Basinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

2.  Endothelial cell changes after photorefractive keratectomy with graded usage of mitomycin C.

Authors:  Hamid Gharaee; Siamak Zarei-Ghanavati; Reza Alizadeh; Mojtaba Abrishami
Journal:  Int Ophthalmol       Date:  2017-06-13       Impact factor: 2.031

3.  Dented corneas related to cardiovascular surgery under general anesthesia.

Authors:  Tomoko Hasegawa; Yoshie Matsui; Masafumi Morita
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-30       Impact factor: 3.117

4.  Pressure restoration and visual recovery time in hypotony after trabeculectomy.

Authors:  Neşe Alagöz; Sariye Taskoparan; Ayse Cigdem Altan; Banu Solmaz; Isıl Basgil Pasaoglu; Berna Basarır; Mehmet Ozgur Cubuk; Tekin Yasar
Journal:  Int Ophthalmol       Date:  2021-05-19       Impact factor: 2.031

5.  Trabeculotomy ab interno with internal limiting membrane forceps for open-angle glaucoma.

Authors:  Houmei Nakasato; Riyo Uemoto; Masaru Isozaki; Akira Meguro; Tatsukata Kawagoe; Nobuhisa Mizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-26       Impact factor: 3.117

6.  Sponge delivery variables and tissue levels of 5-fluorouracil.

Authors:  M R Wilkins; N L Occleston; A Kotecha; L Waters; P T Khaw
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

7.  Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery.

Authors:  S Grisanti; M Diestelhorst; K Heimann; G Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

8.  Paclitaxel-Releasing Thin Biodegradable Film for Prevention of Bleb Avascularity Without Compromising Filtration in Rabbits.

Authors:  Tetsuhiko Okuda; Tomomi Higashide; Mayumi Sakurai; Yukako Fukuhira; Hiroaki Kaneko; Masatsugu Shimomura; Kazuhisa Sugiyama
Journal:  Transl Vis Sci Technol       Date:  2015-06-11       Impact factor: 3.283

9.  Risk factors for failures of trabeculectomies performed without antimetabolites.

Authors:  H Mietz; B Raschka; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

10.  Flap suture--a simple technique for the revision of hypotony maculopathy following trabeculectomy with mitomycin C.

Authors:  Judith Eha; Esther M Hoffmann; Jochen Wahl; Norbert Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.